Top Life Sciences Startups in United Kingdom (2025 Update)
Explore the best Life Sciences companies in United Kingdom. Discover high-growth startups and investment opportunities in our 2025 updated list.
👋🏼 Hi, I'm Bounce Watch. Let's explore what's happening in Top Life Sciences Startups in United Kingdom!
Real-Time Scouting Assistant

Explore Top Life Sciences Startups in United Kingdom featuring 217 Companies
|
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Phytoform | - | Unlocking the genetic potential of crops | Phytoform are making agriculture sustainable & unlocking the genetic potential o... | - |
|
Harpenden | United Kingdom (HQ) | 2017 | Agriculture, Biotechnology +2 | - |
1
Low
|
26
|
143 | 1 year ago | Grant | 5 | 12.5M | 3870 | 5 months ago | ||
|
AlphaBiomics | - | The Precision Medicine Company | Individual patients with a shared ailment can respond very differently to the sa... | - |
|
London | United Kingdom (HQ) | 2018 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
3
|
12 | 6 years ago | Grant | 1 | 100.0K | 353 | 1 year ago | ||
|
Fluidic Analytics | - | A fundamentally new way of quantifying protein interactions for diagnostics, dru... | Fluidic Analytics designs, develops and manufactures tools that seek to revoluti... | - |
|
Cambridge | United Kingdom (HQ) | 2013 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
10
|
974 (13%) | 6 years ago | Series C | 4 | 40.7M | 6959 | 7 months ago | ||
|
Automata | - | Automata is a global biotech company providing robotic automation solutions to t... | Automata was founded with a clear aim: to unlock human potential with automation... | - |
|
London | United Kingdom (HQ) + 2 | 2015 | AI, Biotechnology +2 | [email protected] |
1
Low
|
171
|
25.4K (5%) | 1 year ago | Series Unknown | 6 | 99.8M | 14075 | 5 months ago | ||
|
GENinCode Predictive Gene... | - | Clinical Genetics and Precision Medicine. Safeguarding your future health. | GENinCode specializes in risk assessment and prediction of cardiovascular diseas... | - |
|
Oxford | United Kingdom (HQ) + 2 | 2018 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
47
|
556 (35%) | 1 year ago | Post Ipo Equity | 3 | 7.9M | 3151 | 5 months ago | ||
|
Nuntius Therapeutics | - | Genetic medicines to cure patients with life-threatening diseases | We develop transformative mRNA therapies by leveraging our ground-breaking propr... | - |
|
London | United Kingdom (HQ) | 2021 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
14
|
1.4K | 4 years ago | Pre Seed | 1 | 125.0K | 2014 | 9 months ago | ||
|
Pheon Therapeutics | - | Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs f... | Pheon Therapeutics is leveraging two decades of ADC experience to build a novel... | - |
|
London | United Kingdom (HQ) | 2022 | Biotechnology, Health and Wellness +1 | [email protected] |
1
Low
|
23
|
1.5K (-44%) | 1 year ago | Series B | 3 | 188.0M | 2454 | 6 months ago | ||
|
PredictImmune | - | PredictImmune creates lab tests to guide personalized treatment for immune-media... | PredictImmune is at the forefront of innovative tools for assessing tailored tre... | - |
|
Cambridge | United Kingdom (HQ) | 2017 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
1000
|
483 (-10%) | 2 years ago | Grant | 6 | 31.4M | 16644 | 8 JEI nGn | ||
|
MAASI Enterprises | - | Qualified advisory & consultancy for the life-science industry. Experience Matte... | MAASI Enterprises is a joint venture of highly-skilled & qualified European tech... | - |
|
London | United Kingdom (HQ) + 2 | 2008 | Analytics, Automation +6 | [email protected] |
1
Low
|
44
|
221 | 4 years ago | Undisclosed | 1 | 100.0K | 1108 | 5 months ago | ||
|
Clustermarket | - | Clustermarket is the leading equipment scheduling and management solution for R&... | Clustermarket is the world-leading lab management system helping laboratories op... | - |
|
London | United Kingdom (HQ) | 2016 | B2B, Biotechnology +3 | [email protected] |
1
Low
|
20
|
194.4K (-11%) | 3 years ago | Seed | 4 | 3.7M | 2300 | 6 months ago | ||
|
YellowDog | - | Accelerate your time to market and increase your compute ROI by 5-10x. #HybridCl... | YellowDog optimises compute for technology teams. We work across AI, Life Scienc... | - |
|
Bristol | United Kingdom (HQ) | 2015 | Cloud Infrastructure, Computing +6 | [email protected] |
1
Low
|
22
|
377 (-100%) | 9 years ago | Series A | 1 | 5.4M | 3272 | 5 months ago | ||
|
Base Genomics | - | Unlocking epigenetics, transforming patient outcomes | Base Genomics aims to have a major impact on personalised medicine. We are devel... | - |
|
Oxford | United Kingdom (HQ) | 2019 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
622
|
743 | 5 years ago | Seed | 1 | 9.0M | 93067 | 4 Ujt Wxe | ||
|
Alderley Analytical Ltd | - | World class bioanalytical support from discovery to late phase clinical developm... |
Alderley Analytical is an independent Contract Research Organisation (CRO). We... |
- |
|
Macclesfield | United Kingdom (HQ) | 2014 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
48
|
1.1K (17%) | 6 years ago | Undisclosed | 1 | 300.0K | 2155 | 6 months ago | ||
|
CS Genetics | - | Disruptive platform for single-cell genomics which leverages instrument-free, so... | CS Genetics is developing groundbreaking new technology for single cell genomics... | - |
|
Cambridge | United Kingdom (HQ) + 1 | 2014 | Biotechnology, Health Care +1 | - |
1
Low
|
27
|
619 (18%) | 3 years ago | Debt Financing | 1 | 2.2M | 5740 | 6 months ago | ||
|
VacV Biotherapeutics | - | Developing oncolytic viruses as therapeutics for cancer | VacV Biotherapeutics is a cancer immunotherapy company developing innovative vir... | - |
|
London | United Kingdom (HQ) | 2022 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
6
|
196 (-79%) | 3 years ago | Seed | 1 | 3.0M | 792 | 1 year ago | ||
|
Multiomic Health | - | AI-Enabled Precision Medicine for Metabolic Syndrome-Related Conditions | Multiomic Health is a data-centric therapeutics venture, writing the latest chap... | - |
|
London | United Kingdom (HQ) | 2021 | AI, Biotechnology +3 | [email protected] |
1
Low
|
20
|
1.2K (-20%) | 2 years ago | Seed | 3 | 8.8M | 1574 | 6 months ago | ||
|
Compass Pathways | - | Our vision is a world of mental wellbeing | We are Compass Pathways, a biotechnology company dedicated to accelerating patie... | - |
|
London | United Kingdom (HQ) | 2016 | Biotechnology, Health Care +2 | - |
1
Low
|
246
|
38.9K (13%) | 1 year ago | Post Ipo Equity | 6 | 271.2M | 33558 | 7 months ago | ||
|
VRLab Academy | - | "Teach Better, Learn Better" with VRLab Academy #vreducation #virtuallab | VRLab Academy offers a revolutionary learning platform for Middle Schools, High... | - |
|
London | United Kingdom (HQ) | 2019 | Education, Life Sciences +1 | [email protected] |
1
Low
|
18
|
5.0K (194%) | 1 year ago | Series A | 3 | 320.0K | 6893 | 5 months ago | ||
|
Lifelancer | - | Talent Hiring Platform in Life Sciences & Pharma | Lifelancer is an AI-powered platform for talent hiring in Life Sciences, Pharma,... | - |
|
London | United Kingdom (HQ) + 2 | 2020 | AI, Biopharma +6 | [email protected] |
1
Low
|
11
|
13.6K (-36%) | 3 months ago | Pre Seed | 5 | 532.5K | 23769 | 5 months ago | ||
|
Evonetix Ltd | - | Technology to ignite the biology revolution | We are a Cambridge-based company developing a radically different approach to ge... | - |
|
Cambridge | United Kingdom (HQ) | 2015 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
21
|
3.6K | 2 years ago | Series B | 4 | 68.1M | 5122 | 1 year ago | ||
|
Biorelate Ltd. | - | The most advanced data curation in biopharma. Galactic AI™ is powered by the bes... | Biorelate helps scientists solving the most difficult biomedical challenges of t... | - |
|
Manchester | United Kingdom (HQ) | 2014 | Big Data, Biotechnology +2 | [email protected] |
1
Low
|
41
|
435 | 2 years ago | Series A | 3 | 7.3M | 5501 | 3 months ago | ||
|
Metrion Biosciences | - | Specialists in ion channel biology | Metrion Biosciences is a specialist preclinical drug discovery CRO - your truste... | - |
|
Cambridge | United Kingdom (HQ) | 2015 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
44
|
1.3K | 1 year ago | Series C | 6 | 7.8M | 4832 | 9 nq5 MA9 | ||
|
Hyris | - | Hyris is an innovation-based, fast-growing biotech Company, which aims to democr... |
Hyris is an innovation-based, fast-growing biotech Company, which aims to democr... |
- |
|
London | United Kingdom (HQ) + 2 | 2014 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
31
|
222 | 5 years ago | Series A | 1 | 2.5M | 1985 | 4 months ago | ||
|
OMass Therapeutics | New open positions 3 Jobs | OMass Therapeutics uses high-resolution mass spectrometry to discover drugs, tar... | OMass Therapeutics is a private pharmaceutical company, focused on structural ma... | - |
|
Oxford | United Kingdom (HQ) | 2016 | Life Sciences, Pharmaceutical | [email protected] |
2
Normal
|
82
|
1.8K | 2 years ago | Series B | 5 | 128.0M | 6705 | 3 months ago | ||
|
ONI | - | See protein, DNA and RNA molecules that make life work, in nanoparticles, viruse... | See protein, DNA and RNA molecules that make life work, in nanoparticles, viruse... | - |
|
Oxford | United Kingdom (HQ) + 1 | 2016 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
194
|
19.5K (14%) | 3 years ago | Series B | 6 | 109.4M | 12514 | 3 months ago | ||
|
Engitix Therapeutics | - | Rethinking drug discovery for fibrosis and cancer | To create a healthier future for patients with life-threatening diseases, we are... | - |
|
London | United Kingdom (HQ) + 2 | 2016 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
51
|
1.0K | 3 years ago | Series A | 2 | 60.4M | 6006 | 3 months ago | ||
|
Qkine | - | High quality and novel growth factors for stem cell and organoid culture, regene... | Qkine manufactures high-quality and novel growth factors, supporting scientists... | - |
|
Cambridge | United Kingdom (HQ) | 2016 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
40
|
7.1K | 2 years ago | Series B | 5 | 6.4M | 3654 | 3 months ago | ||
|
Osler Diagnostics | - | Lab-quality diagnostics for anyone, anywhere, at any time. | Osler is a UK-based diagnostics company whose purpose is to enable anyone, anywh... | - |
|
Oxford | United Kingdom (HQ) | 2017 | Health Care, Life Sciences | [email protected] |
1
Low
|
151
|
910 | 2 years ago | Series C | 5 | 177.0M | 86602 | 5 0TM chI | ||
|
Refeyn | - | University of Oxford spinout specializing in mass photometry, a revolutionary ne... | Refeyn, the pioneer of mass photometry, is delivering a disruptive new generatio... | - |
|
Oxford | United Kingdom (HQ) | 2018 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
161
|
15.5K | 4 years ago | Series A | 2 | 30.0M | 6338 | 3 months ago | ||
|
Polymateria | - | Polymateria is a British innovator offering a unique technology to combat plasti... | Polymateria is engineering cost-effective solutions to the global problem of pla... | - |
|
London | United Kingdom (HQ) + 1 | 2016 | Biotechnology, ESG +2 | [email protected] |
1
Low
|
51
|
2.4K | 2 years ago | Series B | 2 | 35.0M | 6856 | 3 months ago | ||
|
Duke Street Bio | - | Pioneering Next Generation Cancer Therapies | Duke Street Bio is focused on exploiting tumour genetic vulnerabilities and harn... | - |
|
London | United Kingdom (HQ) | 2020 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
10
|
109 | 1 year ago | Seed | 4 | 5.1M | 636 | 5 months ago | ||
|
Mogrify | - | Transforming the lives of patients with degenerative diseases through a novel cl... | Mogrify® has developed a proprietary suite of platform technologies that utilize... | - |
|
Cambridge | United Kingdom (HQ) | 2019 | Big Data, Biotechnology +4 | [email protected] |
1
Low
|
38
|
1.8K (-18%) | 1 year ago | Series A | 7 | 48.9M | 8674 | 5 months ago | ||
|
Causaly | - | Unlock R&D productivity with the most complete AI platform for life sciences. | Our mission at Causaly is to redefine the boundaries of human discovery by harne... | - |
|
London | United Kingdom (HQ) | 2018 | AI, Internet +2 | - |
1
Low
|
126
|
9.7K (-28%) | 1 year ago | Series B | 5 | 93.0M | 21785 | 6 months ago | ||
|
Rhizocore Technologies | - | Working with symbiotic fungi to grow healthier, more resilient forests. | At Rhizocore, we develop technologies to grow symbiotic fungi that enhance the g... | - |
|
Edinburgh | United Kingdom (HQ) | 2021 | Agriculture, Biotechnology +1 | - |
1
Low
|
28
|
823 | 1 year ago | Seed | 3 | 4.1M | 4487 | 5 months ago | ||
|
Healx | - | AI-powered and patient-inspired. We accelerate the discovery and development o... | Healx is a mission-driven technology company pioneering the next generation of d... | - |
|
Cambridge | United Kingdom (HQ) | 2014 | AI, Biopharma +3 | [email protected] |
1
Low
|
70
|
4.9K | 10 months ago | Series C | 7 | 114.9M | 18926 | 2 months ago | ||
|
Yaqrit | - | The Liver Disease Company | Yaqrit Limited is developing a family of liver disease treatments that will tran... | - |
|
London | United Kingdom (HQ) | 2014 | Biotechnology, Health Care +3 | [email protected] |
1
Low
|
6
|
172 (-84%) | 4 years ago | Convertible Note | 6 | 17.9M | 678 | 3 years ago | ||
|
Halo Therapeutics | - | The DeepTech Health Company | The DeepTech Health Company | - |
|
Bristol | United Kingdom (HQ) | 2021 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
4
|
527 | 2 years ago | Seed | 1 | 1.5M | 914 | 1 year ago | ||
|
MiroBio Ltd | - | Restoring balance to the immune system to treat disease | Our mission at MiroBio is to deliver transformational immunotherapies for people... | - |
|
Oxford | United Kingdom (HQ) | 2019 | Biotechnology, Life Sciences | [email protected] |
1
Low
|
9
|
200 | 2 years ago | Series B | 2 | 107.0M | 2631 | 1 x1W ils | ||
|
clear_pixel VR | - | Transforming training with cutting-edge VR solutions | clear_pixel VR is a leading provider of virtual reality (VR) training solutions... | - |
|
Penarth | United Kingdom (HQ) | 2020 | EdTech, Education +3 | [email protected] |
1
Low
|
3
|
179 | 1 year ago | Angel | 1 | 378.0K | 772 | 8 months ago | ||
|
Myricx Bio | - | Developing a new class of ADCs based on NMT inhibition to treat cancer | We are a UK biotech company focused on the discovery and development of a comple... | - |
|
London | United Kingdom (HQ) | 2019 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
17
|
1.6K (-16%) | 10 months ago | Series A | 2 | 94.5M | 4024 | 6 months ago |